Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

CUDERMA project: Delphi consensus on quality indicators for certification of dermatology units providing care for hidradenitis suppurativa.

Created on 20 Sep 2026

Authors

A Martorell, F J García Martínez, A Molina Leyva, L Salgado-Boquete, J F Melgosa Ramos, M Robles-Plaza, A de la Cuadra-Grande, E Vilarrasa

Published in

Actas dermo-sifiliograficas. Pages 104743. Sep 19, 2026. Epub Sep 19, 2026.

Abstract

The AEDV CUDERMA project aims to certify dermatology units to standardize clinical practice and ensure quality of care. In line with previous initiatives in psoriasis and dermato-oncology, this study aimed to reach consensus on the aspects to be assessed through quality indicators for the certification of hidradenitis suppurativa (HS) units.
A literature review and a focus group involving dermatologists specializing in the management of patients with HS were conducted to develop a preliminary set of quality indicators, which were subsequently reviewed by a multidisciplinary group of experts. The relevance of these preliminary indicators was then evaluated by a Delphi panel comprising 43 members of the Spanish Hidradenitis Suppurativa Working Group.
The Delphi panel reached consensus on the inclusion of 52 quality indicators.
These indicators will subsequently be standardized for the development of the certification standard for HS units.

PMID:
42762905
Bibliographic data and abstract were imported from PubMed on 20 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 14
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement